Bell: Check out the companies that make headlines before Charter Communications. Cable stock rose 7% after Charter agreed to integrate with rival Cox Communications. The Total Company will change its name to Cox Communications within a year. Constellation Brands – The shares won 3.4% after Berkshire Hathaway revealed that it doubled its beer importer stake. Warren Buffett’s position is currently worth around $2.2 billion. Applied Materials – Semiconductor manufacturers reduced their second quarter revenue by 5% after reporting $71 billion. The $5.26 billion semiconductor revenue disappointed what the $5.31 billion analyst was looking for. Take-Two Interactive Software – Shares fell 1.3% after video game companies issued weaker than expected guidance for full-year bookings. The company expects the figure to be between $5.9 billion and $6 billion, lacking a StreetAccount consensus of $7.82 billion. In the current quarter, we forecast two reservations between $1.25 billion and $100 billion, while analysts were supplying pencils at $1.28 billion. CAVA – The company said it expects sales growth for the same restaurant to ease over the year. Cava reported 10.8% sales growth in the first quarter at comparable locations, but maintained its full-year forecast of 6% to 8% improvement in that category. The decline occurred despite 22 cents’ first quarter earnings per share exceeding the 14 cent analyst estimate, according to LSEG. The stocks had little change. Doxixity – The shares fell 19% after the healthcare platform issued disappointing guidance. Doximity expects first quarter adjusted earnings prior to interest, tax, depreciation or EBITDA to fall below the consensus estimate of $74 million per StreetAccount, ranging from $71 million to $72 million. Both the first quarter and full year revenue guidance also did not meet expectations. Vistra Corp. – Independent Power Producer’s shares jumped over 5% after purchasing seven natural gas facilities from Lotus Infrastructure Partners for $700 million. The gas plants are located in the PJM markets in New England, New York and California. Novo Nordisk – Pharmaceutical inventory slipped 5% after CEO Lars Fruergaard Jørgensen announced he would step down from his position, citing recent market challenges. Jorgensen remains in his position “to support a smooth transition to new leadership for a period of time” as Novo Nordisk searches for alternatives. – Reported by CNBC’s Michelle Fox, Spencer Kimball and Jesse Pound.